These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 30395763)
1. The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity. Metcalfe C; Dougall T; Bird C; Rigsby P; Behr-Gross ME; Wadhwa M; Study POT MAbs; 2019 Jan; 11(1):13-25. PubMed ID: 30395763 [TBL] [Abstract][Full Text] [Related]
2. The first World Health Organization International Standard for in vitro biological activity of darbepoetin. Cowper B; Hockley J; Partridge K; Ferguson J; Rigsby P; Burns C Biologicals; 2020 Jan; 63():33-38. PubMed ID: 31862294 [TBL] [Abstract][Full Text] [Related]
3. Collaborative study for the establishment of Infliximab Biological Reference Preparation Batch 1. Wadhwa M; Rigsby P; Behr-Gross ME Pharmeur Bio Sci Notes; 2020; 2020():49-52. PubMed ID: 32459170 [TBL] [Abstract][Full Text] [Related]
4. Establishment of the first WHO International Standard for etanercept, a TNF receptor II Fc fusion protein: Report of an international collaborative study. Wadhwa M; Bird C; Dilger P; Rigsby P; Jia H; Gross MEB; J Immunol Methods; 2017 Aug; 447():14-22. PubMed ID: 28288790 [TBL] [Abstract][Full Text] [Related]
5. The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring. Wadhwa M; Bird C; Atkinson E; Cludts I; Rigsby P Front Immunol; 2021; 12():636420. PubMed ID: 33936049 [TBL] [Abstract][Full Text] [Related]
6. Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab). Hong J; Lee Y; Lee C; Eo S; Kim S; Lee N; Park J; Park S; Seo D; Jeong M; Lee Y; Yeon S; Bou-Assaf G; Sosic Z; Zhang W; Jaquez O MAbs; 2017; 9(2):364-382. PubMed ID: 28005456 [TBL] [Abstract][Full Text] [Related]
7. International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab. Prior S; Hufton SE; Fox B; Dougall T; Rigsby P; Bristow A; MAbs; 2018 Jan; 10(1):129-142. PubMed ID: 28985159 [TBL] [Abstract][Full Text] [Related]
8. The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab. Jia H; Harikumar P; Atkinson E; Rigsby P; Wadhwa M Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827607 [TBL] [Abstract][Full Text] [Related]
9. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega. Meager A; Gaines Das R; Zoon K; Mire-Sluis A J Immunol Methods; 2001 Nov; 257(1-2):17-33. PubMed ID: 11687235 [TBL] [Abstract][Full Text] [Related]
10. The 2nd International Standard for human granulocyte colony stimulating factor. Wadhwa M; Bird C; Hamill M; Heath AB; Matejtschuk P; Thorpe R; J Immunol Methods; 2011 Mar; 367(1-2):63-9. PubMed ID: 21334342 [TBL] [Abstract][Full Text] [Related]
11. Collaborative study for the establishment of Etanercept Biological Reference Preparation Batch 1. Wadhwa M; Rigsby P; Behr-Gross ME Pharmeur Bio Sci Notes; 2020; 2020():203-205. PubMed ID: 33021469 [TBL] [Abstract][Full Text] [Related]
12. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta. Meager A; Das RG J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271 [TBL] [Abstract][Full Text] [Related]
13. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3. Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853 [TBL] [Abstract][Full Text] [Related]
14. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354. Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160 [TBL] [Abstract][Full Text] [Related]
15. The World Health Organization reference reagent for vascular endothelial growth factor, VEGF165. Robinson CJ; Das RG; Stammers R; Rafferty B Growth Factors; 2006 Dec; 24(4):285-90. PubMed ID: 17381070 [TBL] [Abstract][Full Text] [Related]
16. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). Hermosilla J; Sánchez-Martín R; Pérez-Robles R; Salmerón-García A; Casares S; Cabeza J; Cuadros-Rodríguez L; Navas N BioDrugs; 2019 Apr; 33(2):193-205. PubMed ID: 30875076 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic kits in parasitology: which controls?]. Rossi P Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705 [TBL] [Abstract][Full Text] [Related]
18. The first international standard for human leptin and the first international standard for mouse leptin: comparison of candidate preparations by in vitro bioassays and immunoassays. Robinson CJ; Gaines Das R; Woollacott D J Mol Endocrinol; 2001 Aug; 27(1):69-76. PubMed ID: 11463577 [TBL] [Abstract][Full Text] [Related]
19. Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): report of an international collaborative study. Wadhwa M; Bird C; Dougall T; Rigsby P; Bristow A; Thorpe R; J Immunol Methods; 2015 Jan; 416():17-28. PubMed ID: 25450254 [TBL] [Abstract][Full Text] [Related]
20. The 2nd International Standard for Interleukin-2 (IL-2). Report of a collaborative study. Wadhwa M; Bird C; Heath AB; Dilger P; Thorpe R; J Immunol Methods; 2013 Nov; 397(1-2):1-7. PubMed ID: 23948423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]